Poltrax SI 250mg/125mg Injection
Marketer
Symbiosis Life Sciences Limited
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Poltrax SI 250mg/125mg Injection
Combiflox 250mg/125mg Injection, a dual-action antibiotic, combats diverse bacterial infections by inhibiting microbial proliferation. Administer this medication strictly as directed by a physician. Complete the prescribed treatment regimen; premature cessation may compromise its effectiveness. Common side effects include nausea, vomiting, diarrhea, and dyspepsia. Report any worsening side effects immediately. Seek immediate medical attention for allergic reactions (e.g., rash, itching, swelling, dyspnea). Inform your doctor of all current medications, including those for pre-existing conditions, before commencing treatment. Pregnant or lactating individuals should consult their doctor prior to use. Alcohol consumption should be avoided due to the potential for increased drowsiness. While it typically doesn't impair driving, refrain from driving if experiencing drowsiness or dizziness. Adequate rest, a balanced diet, and sufficient hydration are recommended for optimal recovery. Your physician may order laboratory tests to monitor treatment response.
Uses of Poltrax SI 250mg/125mg Injection
Infections caused by bacteria
Major Benefits of Poltrax SI 250mg/125mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Poltrax SI 250mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Poltrax SI 250mg/125mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
How Poltrax SI 250mg/125mg Injection works:
Ceftriaxone 250mg/Sulbactam 125mg (Poltrax SI Injection) combines a cephalosporin antibiotic with a beta-lactamase inhibitor. Ceftriaxone's antibacterial action disrupts bacterial cell wall synthesis, hindering bacterial survival. Sulbactam's role is to counteract bacterial enzymes that would otherwise degrade Ceftriaxone, thus bolstering its effectiveness.
SAFETY ADVICE
AlcoholSAFE
Alcohol consumption alongside Poltrax SI 250mg/125mg Injection poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Poltrax SI (250mg/125mg) is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; however, data from human trials are scarce.
Breast feedingCAUTION
Administering Poltrax SI 250mg/125mg Injection to breastfeeding mothers requires careful consideration. Temporary cessation of breastfeeding is recommended until the maternal course of treatment concludes and the medication is fully cleared from the mother's system.
DrivingUNSAFE
The administration of Poltrax SI 250mg/125mg Injection can induce drowsiness, visual disturbances, and dizziness. Driving should be avoided if such effects manifest.
KidneyCONSULT YOUR DOCTOR
Data regarding the administration of Poltrax SI 250mg/125mg Injection to individuals with renal impairment is scarce. Physician consultation is recommended.
LiverCAUTION
Exercise caution when administering Poltrax SI 250mg/125mg Injection to individuals suffering from severe hepatic impairment; dosage modification may be necessary. Consult a physician for guidance. Dosage alteration for Poltrax SI 250mg/125mg Injection is unnecessary for patients with mild or moderate liver dysfunction.
What if you forget to take Poltrax SI 250mg/125mg Injection :
Should you forget a scheduled dose of Poltrax SI 250mg/125mg Injection, seek advice from your physician.
Facts to Know About Poltrax SI 250mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently